Identification and characterization of a small inhibitory peptide that can target DNA-PKcs autophosphorylation and increase tumor radiosensitivity

Int J Radiat Oncol Biol Phys. 2012 Dec 1;84(5):1212-9. doi: 10.1016/j.ijrobp.2012.01.092. Epub 2012 May 15.

Abstract

Purpose: The DNA protein kinase catalytic subunit (DNA-PKcs) is one of the critical elements involved in the DNA damage repair process. Inhibition of DNA-PKcs results in hypersensitivity to ionizing radiation (IR); therefore, this approach has been explored to develop molecular targeted radiosensitizers. Here, we aimed to develop small inhibitory peptides that could specifically target DNA-PKcs autophosphorylation, a critical step for the enzymatic activation of the kinase in response to IR.

Methods and materials: We generated several small fusion peptides consisting of 2 functional domains, 1 an internalization domain and the other a DNA-PKcs autophosphorylation inhibitory domain. We characterized the internalization, toxicity, and radiosensitization activities of the fusion peptides. Furthermore, we studied the mechanisms of the inhibitory peptides on DNA-PKcs autophosphorylation and DNA repair.

Results: We found that among several peptides, the biotin-labeled peptide 3 (BTW3) peptide, which targets DNA-PKcs threonine 2647 autophosphorylation, can abrogate IR-induced DNA-PKcs activation and cause prolonged γ-H2AX focus formation. We demonstrated that BTW3 exposure led to hypersensitivity to IR in DNA-PKcs-proficient cells but not in DNA-PKcs-deficient cells.

Conclusions: The small inhibitory peptide BTW3 can specifically target DNA-PKcs autophosphorylation and enhance radiosensitivity; therefore, it can be further developed as a novel class of radiosensitizer.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.

MeSH terms

  • Amino Acid Sequence
  • Biotin / analogs & derivatives*
  • Biotin / chemical synthesis
  • Biotin / pharmacology
  • DNA End-Joining Repair
  • DNA-Activated Protein Kinase / antagonists & inhibitors*
  • DNA-Activated Protein Kinase / metabolism
  • Drug Screening Assays, Antitumor / methods
  • Enzyme Activation / drug effects
  • Histones / biosynthesis
  • Humans
  • Molecular Targeted Therapy / methods*
  • Peptides / chemical synthesis
  • Peptides / pharmacology*
  • Phosphorylation / drug effects
  • Protein Kinase Inhibitors / chemistry
  • Protein Kinase Inhibitors / pharmacology*
  • Radiation Tolerance / drug effects*
  • Recombinant Fusion Proteins / chemistry
  • Recombinant Fusion Proteins / pharmacology
  • Threonine / antagonists & inhibitors

Substances

  • BTW3 peptide
  • H2AX protein, human
  • Histones
  • Peptides
  • Protein Kinase Inhibitors
  • Recombinant Fusion Proteins
  • Threonine
  • Biotin
  • DNA-Activated Protein Kinase